Follow
Fernando Revert Ros
Fernando Revert Ros
CIPF & FS & UCV
Verified email at ucv.es
Title
Cited by
Cited by
Year
Stability of PEI–DNA and DOTAP–DNA complexes: effect of alkaline pH, heparin and serum
I Moret, JE Peris, VM Guillem, M Benet, F Revert, F Dası́, A Crespo, ...
Journal of Controlled Release 76 (1-2), 169-181, 2001
2752001
Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human goodpasture antigen
A Raya, F Revert, S Navarro, J Saus
Journal of Biological Chemistry 274 (18), 12642-12649, 1999
1151999
Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles
A Crespo, A Peydro, F Dasi, M Benet, JJ Calvete, F Revert, SF Aliño
Gene Therapy 12 (11), 927-935, 2005
1032005
Histologic retinacular changes associated with ischemia in painful patellofemoral malalignment
V Sanchis-Alfonso, E Roselló-Sastre, F Revert, A García
Orthopedics 28 (6), 593-599, 2005
602005
Neural growth factor expression in the lateral retinaculum in painful patellofemoral malalignment
V Sanchis-Alfonso, E Roselló-Sastre, F Revert
Acta Orthopaedica Scandinavica 72 (2), 146-149, 2001
572001
Goodpasture antigen-binding protein is a soluble exportable protein that interacts with Type IV collagen: identification of novel membrane-bound isoforms
F Revert, I Ventura, P Martinez-Martinez, F Granero-Molto, F Revert-Ros, ...
Journal of biological chemistry 283 (44), 30246-30255, 2008
412008
Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane
F Revert, R Merino, C Monteagudo, J Macias, A Peydró, J Alcácer, ...
The American journal of pathology 171 (5), 1419-1430, 2007
412007
Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor rnasin
R Botella-Estrada, G Malet, F Revert, F Dasí, A Crespo, O Sanmartín, ...
Cancer Gene Therapy 8 (4), 278, 2001
382001
Polyethyleneimine‐based immunopolyplex for targeted gene transfer in human lymphoma celllines
VM Guillem, M Tormo, F Revert, I Benet, J García‐Conde, A Crespo, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2002
362002
Characterization and expression of multiple alternatively spliced transcripts of the Goodpasture antigen gene region: Goodpasture antibodies recognize recombinant proteins …
JR Penadés, D Bernal, F Revert, C Johansson, VJ Fresquet, J Cervera, ...
European journal of biochemistry 229 (3), 754-760, 1995
311995
Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden
F Revert, F Revert-Ros, R Blasco, A Artigot, E López-Pascual, ...
Oncotarget 9 (13), 11020, 2018
282018
Phosphorylation of the Goodpasture Antigen by Type A Protein Kinases∗
F Revert, JR Penadés, M Plana, D Bernal, C Johansson, E Itarte, ...
Journal of Biological Chemistry 270 (22), 13254-13261, 1995
271995
A human‐specific TNF‐responsive promoter for Goodpasture antigen‐binding protein
F Granero, F Revert, F Revert‐Ros, S Lainez, P Martínez‐Martínez, ...
The FEBS journal 272 (20), 5291-5305, 2005
232005
Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy.
A Mangas-Losada, R García-García, P Leone, MP Ballester, ...
Journal of Translational Medicine 17 (1), 293, 2019
212019
Human Biliverdin Reductase Suppresses Goodpasture Antigen-binding Protein (GPBP) Kinase Activity
T Miralem, PEM Gibbs, F Revert, J Saus, MD Maines
Journal of Biological Chemistry 285 (17), 12551-12558, 2010
192010
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
J Saus, F Revert, F Revert-Ros
US Patent 7,326,768, 2008
152008
Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).
F Revert-Ros, E López-Pascual, F Granero-Moltó, J Macías, R Breyer, ...
Journal of Biological Chemistry 286 (40), 35030-35043, 2011
142011
Conformational diversity of the Goodpasture antigen, the noncollagenous-1 domain of the a3 chain of collagen# 160IV
JJ Calvete, F Revert, M Blanco, J Cervera, C Tárrega, L Sanz, ...
Proteomics, S237, 2006
13*2006
Pharmacodynamic approach to study the gene transfer process employing non-viral vectors
SF Aliño, E Escrig, F Revert, VM Guillem, A Crespo
Biochemical Pharmacology 60 (12), 1845-1853, 2000
102000
GPBP-1 inhibition and its therapeutic use
J Saus, F Revert-Ros, F Revert, C Aguado-Velasco, E López-Pascual, ...
US Patent 9,066,938, 2015
62015
The system can't perform the operation now. Try again later.
Articles 1–20